Abstract
Recent studies using known Rho-associated kinase isoform 1 (ROCK1) inhibitors along with cellular and molecular biology data have revealed a pivotal role of this enzyme in many aspects of cardiovascular function. Here we report a series of ROCK1 inhibitors which were originally derived from a dihydropyrimidinone core 1. Our efforts focused on the optimization of dihydropyrimidine 2, which resulted in the identification of a series of dihydropyrimidines with improved pharmacokinetics and P450 properties.
Citing Articles
View all 8 citing articlesCitation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.
This article has been cited by 8 ACS Journal articles (5 most recent appear below).
Molecular Basis for Small Molecule Inhibition of G Protein-Coupled Receptor Kinases
Kristoff T. Homanand John J. G. TesmerACS Chemical Biology2014 Article ASAPMolecular Basis for Small Molecule Inhibition of G Protein-Coupled Receptor Kinases
Kristoff T.Homanand John J. G.TesmerACS Chemical Biology2014 Article ASAPSmall molecules that inhibit the protein kinase A, G, and C (AGC) family of serine/threonine kinases can exert profound effects on cell homeostasis and thereby regulate fundamental processes such as heart rate, blood pressure, and metabolism, but there is ...
Chemistry and Biology Of Multicomponent Reactions
Alexander Dömling, Wei Wang, and Kan WangChemical Reviews2012 112 (6), 3083-3135Chemistry and Biology Of Multicomponent Reactions
AlexanderDömling, WeiWang, and KanWangChemical Reviews2012 112 (6), 3083-3135
Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors
Rongshi Li, Mathew P. Martin, Yan Liu, Binglin Wang, Ronil A. Patel, Jin-Yi Zhu, Nan Sun, Roberta Pireddu, Nicholas J. Lawrence, Jiannong Li, Eric B. Haura, Shen-Shu Sung, Wayne C. Guida, Ernst Schonbrunn, and Said M. SebtiJournal of Medicinal Chemistry2012 55 (5), 2474-2478Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors
RongshiLi, Mathew P.Martin, YanLiu, BinglinWang, Ronil A.Patel, Jin-YiZhu, NanSun, RobertaPireddu, Nicholas J.Lawrence, JiannongLi, Eric B.Haura, Shen-ShuSung, Wayne C.Guida, ErnstSchonbrunn, and Said M.SebtiJournal of Medicinal Chemistry2012 55 (5), 2474-2478Using high concentration biochemical assays and fragment-based screening assisted by structure-guided design, we discovered a novel class of Rho-kinase inhibitors. Compound 18 was equipotent for ROCK1 (IC50 = 650 nM) and ROCK2 (IC50 = 670 nM), whereas ...
Design and Synthesis of Small Molecule RhoA Inhibitors: A New Promising Therapy for Cardiovascular Diseases?
Jing Deng, Enguang Feng, Sheng Ma, Yan Zhang, Xiaofeng Liu, Honglin Li, Huang Huang, Jin Zhu, Weiliang Zhu, Xu Shen, Liyan Miao, Hong Liu, Hualiang Jiang, and Jian LiJournal of Medicinal Chemistry2011 54 (13), 4508-4522Design and Synthesis of Small Molecule RhoA Inhibitors: A New Promising Therapy for Cardiovascular Diseases?
JingDeng, EnguangFeng, ShengMa, YanZhang, XiaofengLiu, HonglinLi, HuangHuang, JinZhu, WeiliangZhu, XuShen, LiyanMiao, HongLiu, HualiangJiang, and JianLiJournal of Medicinal Chemistry2011 54 (13), 4508-4522RhoA is a member of Rho GTPases, a subgroup of the Ras superfamily of small GTP-binding proteins. RhoA, as an important regulator of diverse cellular signaling pathways, plays significant roles in cytoskeletal organization, transcription, and cell-cycle ...
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A. MeanwellJournal of Medicinal Chemistry2011 54 (8), 2529-2591Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A.MeanwellJournal of Medicinal Chemistry2011 54 (8), 2529-2591
0 件のコメント:
コメントを投稿